Back

Costs and cost-effectiveness of an infection prevention bundle to reduce neonatal sepsis and mortality in Zambia: The Sepsis Prevention in Neonates in Zambia (SPINZ) trial

Sabin, L. L.; West, R. L.; Coffin, S. E.; Machona, S.; Cowden, C.; Mwananyanda, L.; Lukwesa-Musyani, C.; Tembo, J.; Bates, M.; Hamer, D. H.

2026-02-12 infectious diseases
10.64898/2026.02.04.26345617 medRxiv
Show abstract

The Sepsis Prevention in Neonates in Zambia (SPINZ) trial was a prospective observational cohort study conducted in the neonatal intensive care unit of the University Teaching Hospital in Lusaka, Zambia. Introduction of an infection prevention and control (IPC) bundle reduced hospital-associated mortality, total mortality, suspected sepsis, and confirmed bloodstream infections. This companion analysis was undertaken to analyze intervention costs and cost-effectiveness in this low-resource setting. We conducted a retrospective cost analysis, using SPINZ study-related records, and expressed costs in real 2016 US dollars. We also estimated intervention cost-effectiveness using both outcomes from SPINZ (avoided deaths, confirmed infections, and suspected episodes of infection) and estimated disability-adjusted life years (DALYs) averted by the intervention. To provide data for policymakers, a future cost projection was undertaken to estimate costs of the program implemented nationally over a 10-year period in real 2025 US dollars. A total of 2,035 neonates were enrolled from September 2015 to March 2017. Total costs during implementation (introduction of the IPC bundle) (April-May 2016) and the subsequent intervention period were $17,641 and $5,265, respectively, of which most expenses were incurred during the preparation period due to travel and training. During the intervention period, the programs running cost was approximately $478 per month. The estimated cost per death, confirmed infection, and suspected episode averted was $208, $204, and $32, respectively; the estimated cost per DALY averted was $9.5. The future model was estimated to cost an average of $107,561 annually to implement nationally. The analysis indicated that the IPC bundle to prevent sepsis-related neonatal mortality was highly cost-effective. Cost reductions from task-shifting, reduced preparation (start-up) costs, and longer intervention periods would further decrease cost per death averted. IPC bundle implementation can thus be recommended for resource-constrained settings where sepsis and other nosocomial infections are associated with high neonatal mortality.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS Global Public Health
293 papers in training set
Top 0.9%
10.0%
2
Clinical Infectious Diseases
231 papers in training set
Top 0.4%
10.0%
3
PLOS Medicine
98 papers in training set
Top 0.3%
8.3%
4
The American Journal of Tropical Medicine and Hygiene
60 papers in training set
Top 0.8%
4.8%
5
PLOS ONE
4510 papers in training set
Top 32%
4.8%
6
International Journal of Infectious Diseases
126 papers in training set
Top 0.3%
4.3%
7
The Journal of Infectious Diseases
182 papers in training set
Top 0.9%
3.9%
8
BMJ Open
554 papers in training set
Top 5%
3.9%
50% of probability mass above
9
BMC Medicine
163 papers in training set
Top 2%
2.9%
10
Nature Communications
4913 papers in training set
Top 45%
2.6%
11
Scientific Reports
3102 papers in training set
Top 51%
2.1%
12
Journal of Global Health
18 papers in training set
Top 0.2%
1.8%
13
BMJ Global Health
98 papers in training set
Top 2%
1.8%
14
Open Forum Infectious Diseases
134 papers in training set
Top 1%
1.8%
15
eClinicalMedicine
55 papers in training set
Top 0.6%
1.7%
16
Vaccine
189 papers in training set
Top 1%
1.7%
17
Frontiers in Public Health
140 papers in training set
Top 5%
1.6%
18
BMC Infectious Diseases
118 papers in training set
Top 3%
1.5%
19
Trials
25 papers in training set
Top 0.9%
1.5%
20
PLOS Neglected Tropical Diseases
378 papers in training set
Top 4%
1.3%
21
Nutrients
64 papers in training set
Top 1%
0.9%
22
American Journal of Infection Control
12 papers in training set
Top 0.2%
0.9%
23
Frontiers in Medicine
113 papers in training set
Top 6%
0.9%
24
The Lancet Regional Health - Americas
22 papers in training set
Top 0.2%
0.9%
25
Pediatric Infectious Disease Journal
16 papers in training set
Top 0.3%
0.7%
26
Journal of Clinical Medicine
91 papers in training set
Top 7%
0.7%
27
International Journal of Epidemiology
74 papers in training set
Top 3%
0.7%
28
Canadian Medical Association Journal
15 papers in training set
Top 0.4%
0.7%
29
Emerging Infectious Diseases
103 papers in training set
Top 3%
0.7%
30
JAMA Network Open
127 papers in training set
Top 5%
0.7%